Immunovant (IMVT) Shares Outstanding (Diluted) (2020 - 2026)
Immunovant (IMVT) posted Weighted Average Shares Outstanding (Diluted) of 205.55 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 20.3% from 170.87 million a year earlier and up 12.7% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Immunovant's Weighted Average Shares Outstanding (Diluted) came in at 182.42 million, up 20.4% from FY2025.
- Annual Weighted Average Shares Outstanding (Diluted) has increased for five consecutive fiscal years, with a five-year compound annual growth rate of 15.8% (FY2021 to FY2026).
- In prior fiscal years, Immunovant's Weighted Average Shares Outstanding (Diluted) was 151.57 million in FY2025 (+9.8%), 138.1 million in FY2024 (+12.2%), 123.08 million in FY2023 (+12.2%) and 109.68 million in FY2022 (+25.0%).
- The fiscal Q1 2027 figure stands as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to fiscal Q1 2021.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased in each of the last 21 quarters, with growth averaging 15.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 1.7% in fiscal Q3 2025 to 29.3% in fiscal Q2 2022.
- According to Business Quant data, Weighted Average Shares Outstanding (Diluted) for the three prior fiscal quarters was 182.42 million (Q4 2026), 181.51 million (Q3 2026) and 173.64 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Immunovant | 7.38 Bn | 3.97 Bn | - | 206.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 206.67 Mn |
| Jun 30, 2026 | 205.55 Mn |
| Mar 31, 2026 | 182.42 Mn |
| Dec 31, 2025 | 181.51 Mn |
| Sep 30, 2025 | 173.64 Mn |
| Jun 30, 2025 | 170.87 Mn |
| Mar 31, 2025 | 151.57 Mn |
| Dec 31, 2024 | 146.92 Mn |
| Sep 30, 2024 | 146.47 Mn |
| Jun 30, 2024 | 146.09 Mn |
| Mar 31, 2024 | 138.10 Mn |
| Dec 31, 2023 | 144.52 Mn |
| Sep 30, 2023 | 131.16 Mn |
| Jun 30, 2023 | 130.50 Mn |
| Mar 31, 2023 | 123.08 Mn |
| Dec 31, 2022 | 128.57 Mn |
| Sep 30, 2022 | 116.57 Mn |
| Jun 30, 2022 | 116.56 Mn |
| Mar 31, 2022 | 109.68 Mn |
| Dec 31, 2021 | 115.03 Mn |
API Access
Immunovant Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();